Analyst Ratings for aTyr Pharma (LIFE)

LIFE Rating Summary

LIFE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LIFE
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $16.25 (+322.1%) * Over Last 12-Mos
Rating Score: 5.6 / 10   Percentile Rank: 58%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/10/2021 Laidlaw Yale Jen New Coverage Buy
(N/A)
18.00
(N/A)
3.82
(3.85)
0.79% Details
8/17/2020 H.C. Wainwright Joseph Pantginis Upgrade Buy
(Neutral)
13.00
(N/A)
3.81
(3.85)
1.05% Details
Like LIFE Ratings? Also take a look at XBIO, SWKH, KMPH, VNRX

LIFE Ratings News